India Approves More Trials Of First Local COVID-19 MRNA Vaccine
[email protected]04 Oct, 2021News
BENGALURU, Aug 24 (Reuters) ? India has approved further clinical trials for its first local mRNA-based COVID-19 vaccine developed by Gennova Biopharmaceuticals Ltd, the government said on Tuesday, after the injection was found to be safe and effective in an early stage study. Gennova is one of the few pharmaceutical companies worldwide ? including Moderna Inc and Pfizer Inc ? that use mRNA technology in their coronavirus vaccine.
Related Bookmarks
- Understanding Sexual Empowerment And The Importance
- How Can Women�s Relationship Counselling Help
- Air Charter Service and Volga-Dnepr Airlines celebrate 30 years of relief charters
- Why Thai Take-Outs Are The Best?
- SEKO Logistics acquires Bansard International; accelerates global growth
- Reasons Why Python Is Popular Amongst Developers
- What Is The Difference Between Thai & Vietnamese Cuisine?
- Reliable News Feed Writers
- Things You Must Love About Thai Food
- MASkargo and CargoAi partner to digitise Air Cargo in APAC region
Recent Profiles
Fnaf Game
Mcdougall Harris
Tate Meldgaard
Youtube Mp3
Ana Venio
Crowell Wentworth
Krause Holgersen
Willard Bock
Hutchinson Dam
Hanna Hatcher